跳转至内容
Merck
CN

主要文件

查看所有文档

A7502

DL-丙氨酸

≥99% (HPLC)

别名:

(±)-2-氨基丙酸

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

线性分子式:
CH3CH(NH2)COOH
化学文摘社编号:
302-72-7
分子量:
89.09
UNSPSC Code:
12352209
NACRES:
NA.26
PubChem Substance ID:
24891244
EC Number:
206-126-4
Beilstein/REAXYS Number:
1720250
MDL number:
MFCD00064408
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

Quality Level

200

assay

≥99% (HPLC)

form

powder

technique(s)

ligand binding assay: suitable

color

white to off-white

mp

289 °C (dec.) (lit.)

solubility

H2O: soluble

application(s)

peptide synthesis

SMILES string

CC(N)C(O)=O

InChI

1S/C3H7NO2/c1-2(4)3(5)6/h2H,4H2,1H3,(H,5,6)

InChI key

QNAYBMKLOCPYGJ-UHFFFAOYSA-N

Application

DL-丙氨酸是 D-和 L-丙氨酸的外消旋混合物，用作开发氨基酸外消旋拆分技术的模型试剂。DL-丙氨酸可用于研究其与 Cu（II）、Zn（II）和 Cd（II）等过渡金属形成的混合配体（螯合）。

Still not finding the right product?

Explore all of our products under DL-丙氨酸

存储类别

11 - Combustible Solids

wgk

WGK 1

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number
0000281533
0000281533
SLCM4754
SLCJ2684
SLCF9751

没有发现合适的版本？

如果您需要特殊版本，可通过批号或批次号查找具体证书。

搜索COA

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Tatjana Braun et al.
Proceedings of the National Academy of Sciences of the United States of America, 112(30), 9340-9345 (2015-07-01)
The prokaryotic origins of the actin cytoskeleton have been firmly established, but it has become clear that the bacterial actins form a wide variety of different filaments, different both from each other and from eukaryotic F-actin. We have used electron
Randolph M Baral et al.
Journal of feline medicine and surgery, 17(8), 653-666 (2014-10-10)
In-house analysers are commonplace in small animal practices but cannot be calibrated by the operator; therefore, any bias in the generated plasma analyte values cannot be corrected. Guidelines such as grading of renal disease and published reference intervals (RIs) in
Janine Rohrbach et al.
Antiviral therapy, 19(2), 149-159 (2013-09-17)
We investigated changes in biomarkers of liver disease in HIV-HCV-coinfected individuals during successful combination antiretroviral therapy (cART) compared to changes in biomarker levels during untreated HIV infection and to HIV-monoinfected individuals. Non-invasive biomarkers of liver disease (hyaluronic acid [HYA], aspartate
查看所有相关文献

全球贸易项目编号

货号GTIN
A7502-1KG04061833384909
A7502-5KG04061832720562